Long-term outcome of surgical revascularization in patients with reduced left ventricular ejection fraction-a

Helga B Brynjarsdottir1, Arni Johnsen1, Alexandra A Heimisdottir1

  • 1Department of Cardiothoracic Surgery, Landspitali University Hospital, Reykjavik, Iceland.

Insights

Surgical revascularization offers good long-term outcomes for patients with reduced left ventricular ejection fraction (LVEF). However, survival remains significantly lower compared to those with normal LVEF, highlighting the importance of risk stratification.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Outcomes Research

Background:

  • Surgical revascularization is a key treatment for advanced coronary artery disease with reduced left ventricular ejection fraction (LVEF).
  • Long-term outcomes for this patient group are not fully understood.
  • This study investigates long-term results in a nationwide cohort.

Purpose of the Study:

  • To evaluate the long-term outcomes of patients with ischemic cardiomyopathy undergoing surgical revascularization.
  • To compare outcomes between patients with reduced LVEF (≤35%) and normal LVEF (>35%).

Main Methods:

  • Retrospective analysis of 2005 patients undergoing isolated coronary artery bypass grafting (2000-2016).
  • Patients stratified by preoperative LVEF: ≤35% (n=146) vs. >35% (n=1859).
  • Comparison of demographics, major adverse cardiac and cerebrovascular events, and survival rates with a median follow-up of 7.6 years.

Main Results:

  • Patients with LVEF ≤35% had higher rates of diabetes, renal insufficiency, COPD, and prior myocardial infarction.
  • Thirty-day mortality was significantly higher in the reduced LVEF group (8% vs. 2%, P<0.001).
  • Overall survival was substantially lower at 1 and 5 years for the reduced LVEF group (e.g., 5-year survival 69% vs. 91%, P<0.001). Reduced LVEF was independently associated with inferior survival (aHR 2.0, P<0.001).

Conclusions:

  • Coronary artery bypass grafting can yield favorable long-term outcomes even in patients with reduced LVEF.
  • Despite potential benefits, patients with reduced LVEF experience significantly inferior long-term survival compared to those with normal ventricular function.
  • Risk stratification and careful patient selection remain crucial for optimizing outcomes in this population.
Abstract